Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Biopharmaceutics II > Exam 1 > Flashcards

Exam 1 Flashcards

1
Q

Do oral or IV administration dosage forms directly enter the systemic circulation?

A

IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The drug is considered _________ until it enters the blood stream

A

Outside the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

For a PK curve describe Tmax and To for an IV bolus

A

Tmax = To

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

For a PK curve describe Tmax and To for an oral dose

A

Tmax does not equal To

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

For oral doses what causes the Cmax delay?

A

Absorption: access of the drug to the systemic circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

All extravascular delivery routes rely on what process?

A

Absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Kinetically, the absorption of most drugs follow what order process?

A

First order

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 3 key steps in drug absorption?

A
  1. Disintegration (for solid dosage forms)
  2. Dissolution (for solid dosage forms)
  3. Diffusion across the GI membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Compare the stomach to the small intestine

A

Stomach: relatively smooth (low SA)
Small intestine: numerous folds and projections (high SA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many L’s are secreted by the GI tract?

A

8-10L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When going from the stomach to the duodenum what happens to pH and enzymes?

A

Rapid change (pH 5-8)
More enzymes are introduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In the GI tract what areas are the most efficient for drug absorption?

A

Duodenum, jejunum, and upper illeum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where do drugs have longer residence time in the GI tract?

A

Duodenum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the typical range of absorption half-lives for oral solutions and rapidly disintegrating DF?

A

From 15 min to 1 hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the underlying one-compartment model assumptions?

A
  1. Passive diffusion is operative at all times
  2. Both absorption and elimination of a drug follow a first order process
  3. Drug is eliminated in an unchanged form (i.e. no metabolism occured)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Elimination half-life, elimination rate constant, the apparent volume of drug distribution, and system clearance are _______ of ROA

A

Independent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Absorption of a drug from a tablet dosage form includes the following steps?

A

Disintegration to disssolution to diffusion through the membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which PK parameters are independent of ROA?

A

Volume of distribution, elimination half-life, clearance, and elimination rate constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ka = what order constant?

A

First-order

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the value that shows the fraction of drug available at the absorption site (GIT) that is absorbed per unit of time?

A

Ka

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

A high Ka = what

A

Rapid absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

At Tmax
Ka = what

A

Ke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Elimination phase
Ke __ Ka

A

> >

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Absorption phase
Ke __ Ka

A

«

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

When does the elimination process begin after the drug is administered?

A

Almost immediately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is affect by both absorption and elimination during the absorption phase?

A

Cp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

The amount of drug in the body (Db) ______ if the rate of drug absorption larger than the elimination rate

A

Increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Drug Y (150mg) is given as an oral solution and has the following PK parameters: t1/2 = 8 h, ka = 0.25 h-1, Vd = 10 L, F = 1. What will be the plasma concentration at 12 hours after the dose is administered?

A

7 mg/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Manini et al (2005) reported a case of adverse drug reaction in a previously healthy young man who ingested a recommended dose of an over-the-counter (OTC) cold remedy containing pseudoephedrine. Forty-five minutes later, he had an acute myocardial infarction (MI). Elevations of cardiac-specific creatinine kinase and cardiac troponin I confirmed the diagnosis. Cardiac magnetic resonance imaging (MRI) confirmed a regional MI. Cardiac catheterization 8 hours later revealed normal coronary arteries, suggesting a mechanism of vasospasm.

Why the patient developed a sever adverse reaction at a therapeutic dose?

A

The elimination process in the patient is not as fast as expected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

For an oral dosage form, which expression correctly describes the relationship between Ka and Ke at the absorption phase?

Ke = Ka
Ke > Ka
Ka > Ke
Ka&raquo_space; Ke

A

Ka&raquo_space; Ke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is a tool that allows us to tear apart the absorption rate from the elimination rate?

A

The method of residuals

32
Q

The are the method’s prerequisites?

A
  1. The absorption rate constant is larger than the elimination rate constant
  2. Both drug absorption and elimination process follow first-order kinetics
  3. The drug PK follows one-compartment model
33
Q

What is the rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action?

A

Bioavailability

34
Q

What is the fraction of administered dose that enters the systemic circulation?

A

Bioavailability fraction (F)

35
Q

A single intravenous dose of an antibiotic is 250 mg. What would be the corresponding oral dose of the drug, if it has an oral bioavailability of 90%?

A

278 mg

36
Q

A lower bioavailability = ____ drug plasma concentration (Cmax)

A

Lower

37
Q

Why is bioavailability of oral DF incomplete?

A
  1. Excipients
  2. Particle size of API
  3. Polymorphic/solvate form of API
38
Q

BA is measured as the API concentration vs ______ in the systemic circulation

A

Time

39
Q

Cmax =

A

Highest drug concentration in the plasma

40
Q

Tmax =

A

The time required to reach Cmax

41
Q

AUC =

A

Area under the plasma concentration-time curve

42
Q

AUC is ______ affected by the absorption rate

A

NOT

43
Q

Does the relative BA provide the value of the absolute BA of the individual products?

A

No

44
Q

What are the two types of BA?

A

Absolute and Relative

45
Q

Measurement of drug concentration in blood, plasma, or serum after drug administration is the most ______ method of assessing systemic BA

A

Direct

46
Q

What are the two method of computing AUC?

A
  1. Using blood level equations
  2. Using the trapezoidal rule
47
Q

What are the 3 prerequisites for using blood level equations?

A
  1. Known administered dose
  2. Well-fitted blood level curve
  3. 1st order elimination kinetics (most drugs)
48
Q

BA of drugs with dose-dependent PK (AUC is not directly proportional to the dose) is _______ to evaluate

A

Difficult

49
Q

What are the 2 prerequisites for the trapezoidal rule?

A
  1. No blood level curve fitting done
  2. No PK data available
50
Q

What is the advantage of the trapezoidal rule?

A

Compartment-model independent

51
Q

What is the indirect method for estimating bioavailability?

A

BA calculation from the drug urinary excretion data

52
Q

BA can be determined using direct (_______) and indirect (_______) methods

A

direct (determination of AUC)
indirect (urinary excretion)

53
Q

For most drugs, AUC is _______ to the dose

A

Directly proportional

54
Q

What rule can be used to compute the AUC without PK data?

A

Trapezoidal

55
Q

What is the absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study

A

Bioequivalence

56
Q

What is a special type of relative (comparative) bioavailability?

A

Bioequivalence

57
Q

What is when drug’s have the same active ingredient, strength, dosage form, and RoA. That also have the same USP standards (quality, purity, identity) but may differ in shape, color, excipients, release mechanism, packaging, labeling, and expiration date?

A

Pharmaceutical equivalents

58
Q

Pharmaceutical equivalence + Bioequivalence =

A

Therapeutic equivalence

59
Q

What are drugs that have the same active ingredient, solid state form may vary, DF and strength may differ, product may differ with respect to release rate, and alternatives are NOT interchangeable?

A

Pharmaceutical alternatives

60
Q

Bioavailability/Bioequivalence testing subject selection includes?

A

Minimum of 12 adults
Typically, 18-24 subjects are used

61
Q

What makes of the procedure of Bioavailability/Bioequivalence testing?

A
  1. Subject selection
  2. Written consent and physical exam to certify healthy
  3. Subjects fast overnight
  4. Administration of drug with designated amount of water
  5. Analysis of blood and/or urine samples
  6. Tabulating and graphing results
62
Q

In Bioavailability/Bioequivalence testing what is a standard to minimize individual subject variation?

A

2x2 Cross-over design

63
Q

What does it mean if plasma levels show obvious differences in AUC, Cmax, and Tmax?

A

There is no bioequivalence

64
Q

If the results are close and bioequivalence is desired, what must be performed?

A

Statistical analysis (ANOVA)

65
Q

If selecting optimal formulation, Cmax must be _____ MTC and _____ MEC
and what is usually maximized?

A

Below
Above
AUC

66
Q

What is the rule for statistical criteria for bioequivalence? This is the most common criterion to establish BE

A

80/125 Rule

67
Q

BE is concluded if the average BA of the test formulation is with _________ that of the reference formulation?

A

80%, 125%

68
Q

Determine _____ CI for the test formulation and show that AUC (log-transformed) lies betwen ____ and _____ of the reference AUC

A

90%
80%
125%

69
Q

Compare 2 DF of diclofenac sodium, oral tab and IV injection. How would you predict bioavailability of these two DF?
a. Equal
b. Unequal with oral bioavailability being higher
c. Unequal with oral bioavailability being lower

A

C

70
Q

What is the key assumption that allows us to estimate bioavailability using blood level equation?
a.AUC is inversely proportional to administered dose
b.AUC is directly proportional to administered dose
c.AUC is independent of administered dose

A

B

71
Q
  1. Consider 2 different tablet formulations. We have a formulation with 100 mg of the same drug. A study shows that the Tmax of the 2 are different, AUC appears to be the same. These are considered
    a.Pharmaceutical equivalent
    b.Bioavailability
    c.Pharmaceutical alternatives
    d.Therapeutically equivalent
A

A

72
Q

The term biologically available and bioavailability refers to the relative amount of drug that reaches the
a.Small intestine
b.Stomach
c.Systemic circulation
d.Liver
e.Kidney

A

C

73
Q

The AUC of a drug can be determined from a graph by using
a.Law of diminishing returns
b.Rule of 9’s
c.Trapezoidal rule

A

C

74
Q

Differences in bioavailability are most frequently observed with drugs administered by which of the following routes
a.SubQ
b.IV
c.Oral
d.Sublingual
e.IM

A

C

75
Q

Two different oral formulations containing the same dose of the same drug having equal areas under their respective serum concentration time curves
a.Deliver same total amount of drug to bioequivalent in the body but are not necessarily bioequivalent
b.Deliver same total amount of drug in the body are therefore bioequivalent
c.are biorquivalent by definition

A

A

76
Q

Requirements for drug products are considered pharmaceutical alternatives including the same
a.Active drug/precursor
b.DF
c.Salt or ester

A

A

77
Q

If an oral capsule formation of the drug A produces a serum concentration time curve having the same area under the curve as that produced by an equivalent dose of drug a given IV, it can generally be
a.IV is preferred to oral
b.Capsule formulation is essentially completely absorbed
c.Drug is rapidly absorbed
d.All oral DF of A will be bioequivalent
e.No advantage to IV

A

B

Biopharmaceutics II (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions